000 | 00988 a2200277 4500 | ||
---|---|---|---|
005 | 20250517024519.0 | ||
264 | 0 | _c20160414 | |
008 | 201604s 0 0 eng d | ||
022 | _a1873-7560 | ||
024 | 7 |
_a10.1016/j.eururo.2014.12.065 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aBuchwald, Zachary S | |
245 | 0 | 0 |
_aWords of wisdom. Re: MPDL3280A (anti-PD-L1) treatment leads to clinical activity in metastatic bladder cancer. _h[electronic resource] |
260 |
_bEuropean urology _cMay 2015 |
||
300 |
_a975 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Comment | ||
650 | 0 | 4 |
_aAntibodies, Monoclonal _xtherapeutic use |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aImmunotherapy |
650 | 0 | 4 | _aMale |
650 | 0 | 4 |
_aUrinary Bladder Neoplasms _xtherapy |
700 | 1 | _aEfstathiou, Jason A | |
773 | 0 |
_tEuropean urology _gvol. 67 _gno. 5 _gp. 975 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.eururo.2014.12.065 _zAvailable from publisher's website |
999 |
_c24777695 _d24777695 |